퍼시픽 바이오사이언시즈 (PACB) 주가

퍼시픽 바이오사이언시즈(PACB)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $1.37 (-0.72%), 시가총액 $0.36B, 52주 최저~최고 $0.91 ~ $2.67.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on

핵심 지표

• 현재가: $1.37 (-0.72%)
• 시가총액: $0.36B
• 52주 최저~최고: $0.91 ~ $2.67
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

퍼시픽 바이오사이언시즈의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

퍼시픽 바이오사이언시즈 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.7857

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 148.33
• 순이익률: -0.80%
• 영업이익률: -1.03%

자주 묻는 질문